Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Howard A. “Skip” Burris III, MD
lungcanc
Breaking News Briefs
lungcanc
ALK Testing in Europe
lungcanc
Immunotherapy Adverse-Event Treatment Resource Guide
lungcanc
Funding Fellowships to Find a Cure: ‘It’s About the People’
lungcanc
Bruce Ratner
lungcanc
Lung Cancer Immunotherapy Meeting to Discuss New Topics, Emerging Themes
lungcanc
Management of Immunotherapy Toxicity in NSCLC
lungcanc
Inaugural Africa Conference: Finding Parallels Among Disparate Realities
lungcanc
An American Perspective on the European Lung Cancer Screening Implementation Plans
lungcanc
1
...
28
29
30
...
53
Page 29 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
